Everspin Technologies: New Use Cases Can Propel Its Growth

Everspin Technologies is rated 'Buy' with a $27/share price target, implying ~74% upside potential. The MRAM growth outlook calls for revenue rising from $55M in FY25 to $100M by FY29, supported by data center and space infrastructure adoption. The model highlights >50% gross margins, positive free cash flow, and a strong balance sheet with $44M cash and zero debt.

Analysis

The key issue is not whether MRAM is a good niche technology, but whether it can translate design wins into a durable revenue curve fast enough to justify a material re-rating. If data center and space exposure are real, the stock should trade more like an option on an emerging qualification cycle than a normal semiconductor multiple; the upside comes from margin durability and operating leverage, not near-term scale. That said, at this size, any single customer delay can swamp the model, so the equity is likely to remain headline-sensitive until order cadence becomes visible.

Winners are likely the company’s channel partners and end customers that need non-volatile memory in harsh environments, because MRAM’s value proposition is substitution, not substitution-plus-growth. The bigger second-order loser, if adoption accelerates, is higher-cost legacy embedded memory vendors and any incumbent solution that loses sockets in industrial, aerospace, or server subsystems. But the broader memory complex is probably not the right read-through: this is a specialty attachment-rate story, not a cycle call on DRAM/NAND.

The main risk is timing. Revenue from $55M to $100M by FY29 is a multi-year claim, and the market will likely discount it until management proves it with backlog, repeat orders, and customer concentration data. The structural bull case weakens if gross margin drifts below the low-50s, if cash burn resumes, or if qualification ramps slip by even 1-2 quarters; the stock could derate sharply because current valuation already embeds scarcity value.

Contrarian view: consensus may be over-weighting TAM and under-weighting adoption friction. In specialty semis, product superiority rarely matters as much as qualification inertia, second-source requirements, and purchasing conservatism. If the next two quarters do not show sequential acceleration, the stock can give back most of the target-driven upside even if the long-term story remains intact.

Key Decisions for Investors

• Take a small starter long MRAM only on pullbacks, not on strength; use it as a 6-12 month secular adoption trade, with a hard thesis break if gross margin falls below ~50% or cash starts declining again.
• Pair trade: long MRAM / short MU for the next 1-3 months to isolate specialty-memory adoption from commodity memory beta; the trade works if MRAM outperforms on customer wins while DRAM/NAND fundamentals stay noisy.
• Set a catalyst watch for the next two earnings prints: if management does not show sequential revenue acceleration or commentary on design-win conversion, treat the $27 target as narrative-driven and reduce exposure.
• Avoid sizing this like a normal semiconductor long; liquidity and customer concentration argue for a max 25-50 bps portfolio weight until backlog and repeat-order data confirm the multi-year revenue path.